🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Novo Nordisk A/S (CPH:NOVO.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
263.20
-1.95 (-0.74%)
Nov 20, 2026, 12:06 PM CET

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of DKK 1.16 trillion. The enterprise value is 1.25 trillion.

Market Cap1.16T
Enterprise Value 1.25T

Important Dates

The last earnings date was Wednesday, November 4, 2026.

Earnings Date Nov 4, 2026
Ex-Dividend Date Aug 14, 2026

Share Statistics

Novo Nordisk has 4.41 billion shares outstanding. The number of shares has decreased by -0.20% in one year.

Current Share Class 3.33B
Shares Outstanding 4.41B
Shares Change (YoY) -0.20%
Shares Change (QoQ) -0.29%
Owned by Insiders (%) 0.01%
Owned by Institutions (%) 28.12%
Float 3.16B

Valuation Ratios

The trailing PE ratio is 10.33 and the forward PE ratio is 12.03. Novo Nordisk's PEG ratio is 5.05.

PE Ratio 10.33
Forward PE 12.03
PS Ratio 3.45
PB Ratio 5.29
P/TBV Ratio 10.86
P/FCF Ratio 16.07
P/OCF Ratio 9.05
PEG Ratio 5.05
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.77, with an EV/FCF ratio of 17.30.

EV / Earnings 10.95
EV / Sales 3.72
EV / EBITDA 6.77
EV / EBIT 7.32
EV / FCF 17.30

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 0.62.

Current Ratio 0.84
Quick Ratio 0.63
Debt / Equity 0.62
Debt / EBITDA 0.73
Debt / FCF 1.88
Interest Coverage 65.67

Financial Efficiency

Return on equity (ROE) is 58.38% and return on invested capital (ROIC) is 42.60%.

Return on Equity (ROE) 58.38%
Return on Assets (ROA) 19.05%
Return on Invested Capital (ROIC) 42.60%
Return on Capital Employed (ROCE) 48.45%
Weighted Average Cost of Capital (WACC) 5.78%
Revenue Per Employee 4.83M
Profits Per Employee 1.64M
Employee Count66,700
Asset Turnover 0.60
Inventory Turnover 1.13

Taxes

In the past 12 months, Novo Nordisk has paid 31.49 billion in taxes.

Income Tax 31.49B
Effective Tax Rate 21.77%

Stock Price Statistics

The stock price has decreased by -15.66% in the last 52 weeks. The beta is 0.37, so Novo Nordisk's price volatility has been lower than the market average.

Beta (5Y) 0.37
52-Week Price Change -15.66%
50-Day Moving Average 263.37
200-Day Moving Average 279.33
Relative Strength Index (RSI) 43.99
Average Volume (20 Days) 5,200,285

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of DKK 333.65 billion and earned 113.18 billion in profits. Earnings per share was 25.49.

Revenue333.65B
Gross Profit 278.04B
Operating Income 169.42B
Pretax Income 144.67B
Net Income 113.18B
EBITDA 181.56B
EBIT 169.42B
Earnings Per Share (EPS) 25.49
Full Income Statement

Balance Sheet

The company has 46.35 billion in cash and 134.48 billion in debt, with a net cash position of -88.13 billion or -19.99 per share.

Cash & Cash Equivalents 46.35B
Total Debt 134.48B
Net Cash -88.13B
Net Cash Per Share -19.99
Equity (Book Value) 217.80B
Book Value Per Share 49.40
Working Capital -38.68B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 127.33 billion and capital expenditures -55.64 billion, giving a free cash flow of 71.68 billion.

Operating Cash Flow 127.33B
Capital Expenditures -55.64B
Depreciation & Amortization 12.13B
Net Borrowing 31.03B
Free Cash Flow 71.68B
FCF Per Share 16.26
Full Cash Flow Statement

Margins

Gross margin is 83.33%, with operating and profit margins of 50.78% and 33.92%.

Gross Margin 83.33%
Operating Margin 50.78%
Pretax Margin 43.36%
Profit Margin 33.92%
EBITDA Margin 54.41%
EBIT Margin 50.78%
FCF Margin 21.48%

Dividends & Yields

This stock pays an annual dividend of 11.70, which amounts to a dividend yield of 4.45%.

Dividend Per Share 11.70
Dividend Yield 4.45%
Dividend Growth (YoY) 0.43%
Years of Dividend Growth 8
Payout Ratio 45.85%
FCF Payout Ratio 71.97%
Buyback Yield 0.20%
Shareholder Yield 4.68%
Earnings Yield 9.68%
FCF Yield 6.22%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Analyst Forecast

The average price target for Novo Nordisk is 299.91, which is 13.95% higher than the current price. The consensus rating is "Hold".

Price Target 299.91
Price Target Difference 13.95%
Analyst Consensus Hold
Analyst Count 26
Revenue Growth Forecast (3Y) 2.26%
EPS Growth Forecast (3Y) 1.42%

Stock Splits

The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.

Last Split Date Sep 13, 2023
Split Type Forward
Split Ratio 2

Scores

Novo Nordisk has an Altman Z-Score of 4.04 and a Piotroski F-Score of 6.

Altman Z-Score 4.04
Piotroski F-Score 6